Mel Sorensen - 01 May 2025 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
President and CEO, Director
Signature
/s/ J. Mel Sorensen
Issuer symbol
GRTX
Transactions as of
01 May 2025
Transactions value $
$0
Form type
4
Filing time
05 May 2025, 16:17:46 UTC
Previous filing
20 Aug 2024
Next filing
24 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sorensen Mel President and CEO, Director C/O GALERA THERAPEUTICS, INC., 101 LINDENWOOD DRIVE, SUITE 225, MALVERN /s/ J. Mel Sorensen 05 May 2025 0001444783

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +6M $0.00 6M 01 May 2025 Common Stock 6M $0.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on June 1, 2025.